Bio-Bridge, Xinheng Baide Biotechnology Co. Ltd. deal

Bio-Bridge will acquire 51% of Xinheng, a bovine serum manufacturer, for RMB6 million ($865,000). The deal is expected to close in May. In November, Bio-Bridge acquired 51% of Lanzhou Roya Biotechnolo...